GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » Total Liabilities

Acepodia (ROCO:6976) Total Liabilities : NT$405.55 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Acepodia Total Liabilities?

Acepodia's Total Liabilities for the quarter that ended in Jun. 2024 was NT$405.55 Mil.

Acepodia's quarterly Total Liabilities increased from Jun. 2023 (NT$356.22 Mil) to Dec. 2023 (NT$384.47 Mil) and increased from Dec. 2023 (NT$384.47 Mil) to Jun. 2024 (NT$405.55 Mil).

Acepodia's annual Total Liabilities increased from Dec. 2021 (NT$5,360.64 Mil) to Dec. 2022 (NT$6,883.34 Mil) but then declined from Dec. 2022 (NT$6,883.34 Mil) to Dec. 2023 (NT$384.47 Mil).


Acepodia Total Liabilities Historical Data

The historical data trend for Acepodia's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acepodia Total Liabilities Chart

Acepodia Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Liabilities
963.47 5,360.64 6,883.34 384.47

Acepodia Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Liabilities Get a 7-Day Free Trial - 6,883.34 356.22 384.47 405.55

Acepodia Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Acepodia's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=137.59+(233.45+13.432
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=384.47

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=6818.521-6434.049
=384.47

Acepodia's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=106.496+(285.624+13.432
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=405.55

Total Liabilities=Total Assets (Q: Jun. 2024 )-Total Equity (Q: Jun. 2024 )
=6994.616-6589.064
=405.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acepodia Total Liabilities Related Terms

Thank you for viewing the detailed overview of Acepodia's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Acepodia Business Description

Traded in Other Exchanges
N/A
Address
17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175
Acepodia Inc is a clinical stage biotechnology company engaged to develop innovative highly effective first-in-class cell therapies by using Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Acepodia Headlines

No Headlines